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Abstract 
Background: Genetic and epigenetic variability contributes to the susceptibility and pathogenesis of autoimmune 
diseases. T cells play an important role in several autoimmune conditions, including lupus, which is more common 
and more severe in people of African descent. To investigate inherent epigenetic differences in T cells between eth‑
nicities, we characterized genome‑wide DNA methylation patterns in naïve CD4+ T cells in healthy African‑Americans 
and European‑Americans, and then confirmed our findings in lupus patients.
Results: Impressive ethnicity‑specific clustering of DNA methylation profiling in naïve CD4+ T cells was revealed. 
Hypomethylated loci in healthy African‑Americans were significantly enriched in pro‑apoptotic and pro‑inflammatory 
genes. We also found hypomethylated genes in African‑Americans to be disproportionately related to autoimmune 
diseases including lupus. We then confirmed that these genes, such as IL32, CD226, CDKN1A, and PTPRN2 were simi‑
larly hypomethylated in lupus patients of African‑American compared to European‑American descent. Using patch 
DNA methylation and luciferase reporter constructs, we showed that methylation of the IL32 promoter region reduces 
gene expression in vitro. Importantly, bisulfite DNA sequencing demonstrated that cis‑acting genetic variants within 
and directly disrupting CpG sites account for some ethnicity‑specific variability in DNA methylation.
Conclusion: Ethnicity‑specific inherited epigenetic susceptibility loci in CD4+ T cells provide clues to explain differ‑
ences in the susceptibility to autoimmunity and possibly other T cell‑related diseases between populations.
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Background
DNA methylation is part of the epigenetic regulatory sys-
tem in the cell and serves as an intermediary between an 
individual’s environment and their genetic background. 
One classic example is monozygotic twins; they share a 
nearly identical genotype, but display increased differ-
ences in DNA methylation and histone acetylation as 
they age [1]. Differences in DNA methylation also con-
tribute to the phenotypic variation present between 
individuals and ethnicities. Epigenetic differences 
between ethnicities are an important consideration when 
investigating autoimmune disorders with a pattern of 
heterogeneous risk. Systemic lupus erythematosus (SLE, 
or lupus) and scleroderma both show a preponderance of 
risk and younger age of onset among African-Americans 
compared to European-Americans, while type-1 diabetes 
and multiple sclerosis have higher incidence rates among 
European-Americans [2]. Ethnicity can also be associated 
with disease severity and outcome. In a survey of SLE 
patients in southeastern Michigan, there was a 2.2-fold 
increase in renal involvement and 3.4-fold increase in 
end-stage renal disease in African-Americans compared 
to European-Americans [3].
Previous studies of the DNA methylation patterns 
in different ethnicities revealed that peripheral blood 
cells from non-Hispanic African-Americans display 
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a global decrease in methylation of the retrotranspo-
son LINE-1 compared to European-Americans [4]. 
DNA methylation differences seen in individuals of 
African-American, European-American, and Han Chi-
nese ancestry were associated with genes related to 
xenobiotic metabolism and immune system function, 
among others [5]. These examples of epigenetic vari-
ation between ethnicities may provide answers as to 
what contribution inherent epigenetic differences make 
to the development and progression of autoimmune 
diseases.
DNA methylation changes in CD4+ T cells play an 
important role in the pathogenesis and clinical pres-
entation of SLE, and these changes can be identified 
in naïve CD4+ T cells prior to T cell activation [6, 7]. 
Because SLE is more common and more severe in Afri-
can-Americans compared to European-Americans, we 
hypothesized that inherent T cell DNA methylation dif-
ferences might exist in African-Americans compared 
to European-Americans. To address this hypothesis, we 
evaluated the DNA methylome of naïve CD4+ T cells 
in healthy African-American and European-American 
populations, and then confirmed our findings in SLE 
patients.
Results
DNA methylation differences in naïve CD4+ T cells 
between African‑Americans and European‑Americans
The Illumina Infinium HumanMethylation450 microar-
ray interrogates the DNA methylation status of a total 
485,512 probes. Differential methylation between Afri-
can-American and European-American individuals was 
performed on 425,161 probes that remained after initial 
filtering. There was a clear distinction in the naïve CD4+ 
T cell DNA methylation profile between African-Ameri-
cans and European-Americans as demonstrated in a mul-
tidimensional scaling plot of the 1000 most variable array 
probes after batch effect adjustment (Fig. 1). DNA meth-
ylation profile clustering can distinguish between the two 
ethnicities, with the exception of one European-Amer-
ican individual with a methylation profile that clustered 
with our African-American samples.
Applying a threshold of |Δβ|  >  0.1 and FDR-adjusted 
P value ≤0.05, we found 306 hypomethylated CpG sites 
associated with 144 genes and 375 hypermethylated CpG 
sites associated with 164 genes in naïve CD4+ T cells 
isolated from African-Americans compared to European 
-Americans (Additional file 1: Table S1). The most hypo-
methylated gene was NRGN (Δβ = −0.41; P = 1.82E−05) 
(Table  1). This gene encodes the protein neurogra-
nin  (Ng), which is a regulator of the calcium-binding 
calmodulin protein [8]. Other hypomethylated genes in 
African-Americans included GSTM1, IL32, and CD226.
The most hypermethylated CpG site in African-Amer-
icans (Δβ = 0.39; P = 1.99E−08) was not associated with 
a gene. Other hypermethylated loci were associated with 
CCS (Δβ = 0.36; P = 4.78E−05) and DUSP22 (Δβ = 0.25; 
P  =  3.16E−04). CCS encodes a copper chaperone for 
super oxide dismutase that delivers copper ions to cop-
per-dependent enzymes [9]. DUSP22 encodes a protein 
tyrosine phosphatase [10].
Gene ontologies associated with apoptosis are 
overrepresented in hypomethylated CpG sites 
in African‑Americans
Using the functional annotation database DAVID, we 
explored biological processes and cellular component 
gene ontologies in genes associated with hypomethylated 
CpG sites in healthy African-Americans. We found genes 
related to regulating and promoting cellular apoptosis 
to be enriched among hypomethylated genes with the 
most significant being “positive regulation of apoptosis” 
(GO:0043065, FDR = 8.4 %) (Table 2). Hypermethylated 
Fig. 1 Multidimensional scaling plots of the Euclidean distances 
calculated using the 1000 most variable CpG sites after batch effect 
adjustment with ComBat and color coded by ethnicity (a). b Shows a 
kernel density estimate distribution of all β values before (red line) and 
after (blue line) batch effect adjustment. Density is a unit‑less value 
of the probability distribution of probes within a certain range of β 
values
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CpG sites in African-American naïve CD4+ T cells 
were found to be enriched for gene ontologies  related 
to the regulation of muscle adaptation and contraction 
(GO:0043502, FDR = 4.9 %; GO:0006936, FDR = 5.2 %), 
and did not appear to be related to naïve CD4+ T cell 
activity or growth.
Hypomethylated genes in African‑Americans are enriched 
in genes related to autoimmunity and are hypomethylated 
in lupus patients
As pro-apoptotic gene ontologies were associated with 
hypomethylated genes in African-Americans, and 
because autoimmune diseases such as lupus tend to be 
more common and more severe in African-Americans, 
we investigated if hypomethylated genes in naïve CD4+ 
T cells in African-Americans are enriched for autoim-
munity-related genes. Using the literature mining soft-
ware IRIDESCENT [11–13], which scans all published 
MEDLINE abstracts for co-occurring terms (and their 
synonyms), we identified how many of these 144 genes 
had been published with the terms “autoimmune dis-
eases” and “SLE”. We found 27/144 hypomethylated 
genes had been associated with “autoimmune diseases” 
(P < 0.005), and 18/144 associated with “SLE” (P < 0.037) 
within MEDLINE abstracts (Fig. 2). Each gene needed to 
be co-mentioned a minimum of three times with each 
query term to be considered “associated”. To validate that 
the CpG sites within the 18 lupus-related genes that are 
hypomethylated in healthy African-Americans compared 
to European-Americans are also differentially methylated 
Table 1 Top 30 most hypomethylated CpG sites in naïve CD4+ T cells from healthy African-Americans compared to Euro-
pean Americans






Δβ P value Location (chromosome: 
HG19 position)
cg26069044 NRGN 0.32 0.73 −0.41 1.82E−05 11:124613956
cg19651115 0.33 0.71 −0.37 1.20E−10 12:11700343
cg18232235 0.54 0.88 −0.34 3.61E−07 12:11700321
cg15131258 C20orf71 0.38 0.69 −0.31 5.45E−10 20:31805182
cg11738485 HOOK2 0.15 0.45 −0.31 8.55E−03 19:12877000
cg22068400 0.22 0.52 −0.31 9.56E−07 2:90016264
cg04193820 RNF135 0.17 0.46 −0.30 5.48E−12 17:29297414
cg08896939 RNF135 0.20 0.49 −0.29 2.15E−10 17:29297380
cg27436995 FBXL16 0.36 0.64 −0.29 1.54E−03 16:743998
cg17920646 0.39 0.67 −0.29 8.67E−04 8:216578
cg18136963 0.13 0.41 −0.28 1.54E−03 6:139013146
cg10578777 0.57 0.84 −0.27 2.07E−04 12:7781093
cg27415324 0.59 0.85 −0.27 1.38E−07 22:17901078
cg06864789 0.19 0.45 −0.26 9.11E−04 6:139012992
cg24506221 GSTM1 0.07 0.32 −0.26 2.94E−03 1:110230401
cg06417478 HOOK2 0.16 0.41 −0.25 3.19E−03 19:12876846
cg04554929 0.10 0.35 −0.25 3.27E−05 8:105342491
cg06202470 0.68 0.93 −0.24 2.13E−07 12:11700489
cg25828445 0.57 0.81 −0.24 3.08E−04 12:7781288
cg00817464 XPNPEP1 0.42 0.65 −0.24 4.65E−03 10:111662876
cg05886698 DDX53 0.67 0.90 −0.24 1.44E−06 X:23018110
cg24536782 0.36 0.60 −0.24 3.65E−03 8:216659
cg00239353 IL32 0.51 0.74 −0.23 1.52E−08 16:3115133
cg04752818 INTS1 0.63 0.87 −0.23 3.35E−06 7:1536622
cg08477332 S100A14 0.22 0.45 −0.23 1.47E−03 1:153590243
cg02025737 0.61 0.84 −0.23 2.46E−03 15:33384751
cg10044179 C21orf81 0.28 0.50 −0.22 2.43E−05 21:15352983
cg15641364 TAGLN2 0.17 0.40 −0.22 2.71E−07 1:159892206
cg01280390 CSGALNACT1 0.27 0.49 −0.22 4.86E−05 8:19363452
cg16154810 CERK 0.24 0.46 −0.22 6.06E−03 22:47135258
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between the two ethnicities in lupus, we compared DNA 
methylation levels across these sites between African-
American and European-American lupus patients. We 
demonstrate that the majority of these CpG sites remain 
differentially methylated between the two ethnicities dur-
ing disease, including multiple CpG sites in the cytokine 
gene IL32 promoter region (Table 3). 
Gene co‑regulation analysis
To further characterize differential epigenetic accessibil-
ity in naïve CD4+ T cells between African-Americans 
and European-Americans, we investigated the transcrip-
tional co-regulation of the 144 hypomethylated genes in 
African-Americans using a meta-analysis of 3900 human 
gene expression microarrays [14]. Pair-wise gene–gene 
correlations of the 144 genes revealed three tightly co-
regulated gene blocks (Fig. 3). Literature mining analysis 
for commonality between the genes within each block, 
using IRIDESCENT, revealed general relationships 
to IL-2 signaling, cell migration, and the glutathione 
S-transferase gene GSTO1, for the gene groups in blocks 
1, 2 and 3, respectively (Fig. 3).
Cis‑acting genetic variants accounts for some 
population‑specific methylation differences
To investigate if cis-acting genetic variants might explain 
at least some of the DNA methylation differences 
between African-American and European-American 
individuals, the presence of single-nucleotide polymor-
phisms (SNPs) with a minor allele frequency of >1  % 
located within the top 30 hypomethylated CpG dinucle-
otides in African-Americans was determined using the 
UCSC Genome Browser. These SNPs located beyond the 
array probe sequences do not influence probe hybridi-
zation and the technical ability of probes to accurately 
measure DNA methylation. The top 30 hypomethylated 
CpG sites included four SNPs (substitutions or inser-
tion–deletions), three of which were associated with 
genes including NRGN, BPIFA3 (C20orf71) and INTS1. 
Rs55661361 is an intragenic SNP located in the NRGN 
CpG site most hypomethylated in African-Americans. 
The ancestral A allele changes the CpG site in NRGR to 
a CpA site, which would prevent the methylation of the 
cytosine residue in this locus. The ancestral A allele has 
a frequency of 79 and 37 % in the Yoruba from Ibadan, 
Table 2 Biological process and  cellular component gene ontologies represented in  hypomethylated CpG sites in  naïve 
CD4+ T cells from healthy African-Americans
GO term GO term ID Fold enrichment False discovery rate (%) Gene count Genes
Positive regulation of apoptosis GO:0043065 3.0 8.4 10 TNFRSF10A, COL18A1, CDKN1A, AHRR, 
UNC13D, RIPK1, GRIN1, AKAP13, 
VAV2, PRODH
Positive regulation of programmed 
cell death
GO:0043068 3.0 8.7 10 TNFRSF10A, COL18A1, CDKN1A, AHRR, 
UNC13D, RIPK1, GRIN1, AKAP13, 
VAV2, PRODH
Regulation of kinase activity GO:0043549 3.3 9.0 9 TNFRSF10A, NCK2, CDKN1A, DAB1, 
ADCY9, RIPK1, CD81, CERK, VAV2
Positive regulation of cell death GO:0010942 3.0 9.0 10 TNFRSF10A, COL18A1, CDKN1A, AHRR, 
UNC13D, RIPK1, GRIN1, AKAP13, 
VAV2, PRODH
Regulation of transferase activity GO:0051338 3.2 11.3 9 TNFRSF10A, NCK2, CDKN1A, DAB1, 
ADCY9, RIPK1, CD81, CERK, VAV2
Positive regulation of kinase activity GO:0033674 4.0 12.6 7 TNFRSF10A, DAB1, ADCY9, RIPK1, CD81, 
CERK, VAV2
Regulation of leukocyte activation GO:0002694 4.7 13.1 6 NCK2, CDKN1A, UNC13D, AP3D1, 
CD226, RC3H1
Positive regulation of transferase 
activity
GO:0051347 3.8 14.9 7 TNFRSF10A, DAB1, ADCY9, RIPK1, CD81, 
CERK, VAV2
Regulation of cell activation GO:0050865 4.5 16.0 6 NCK2, CDKN1A, UNC13D, AP3D1, 
CD226, RC3H1
Induction of apoptosis GO:0006917 3.3 16.4 8 TNFRSF10A, CDKN1A, AHRR, UNC13D, 
RIPK1, AKAP13, VAV2, PRODH
Induction of programmed cell  
death
GO:0012502 3.3 16.6 8 TNFRSF10A, CDKN1A, AHRR, UNC13D, 
RIPK1, AKAP13, VAV2, PRODH
Regulation of cell communication GO:0010646 2.0 17.2 16 PLAT, GNAI3, KLK5, GRIN1, AKAP13, 
RGNEF, VAV2, ARHGEF10, TNFRSF10A, 
NCK2, ADAP2, RIPK1, ZDHHC13, 
CD81, CD226, KNDC1
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Nigeria (YRI) and the European-Americans from Utah, 
USA (CEU) populations, respectively. This suggests that 
loss of DNA methylation in this CpG site in African-
Americans might be explained by this genetic variation. 
To confirm this, we performed bisulfite DNA sequenc-
ing in 10 African-American and 21 European-American 
healthy individuals to determine the genotype–methyla-
tion relationship in this locus. We found a distinct pat-
tern of association between the genotype of rs55661361 
and the average DNA methylation of NRGN (Fig.  4). 
Individuals in this study can be categorized into high 
methylation, intermediate methylation, and low meth-
ylation groups representing three genotypes: G/G, G/A 
and A/A in rs55661361, respectively. The high methyla-
tion group (G/G) included 15 individuals (13 EA; 2 AA; 
average  % methylation = 81.6), the intermediate meth-
ylation group (G/A) included 13 individuals (8 EA; 5 AA; 
average  % methylation = 56.5), and the low methylation 
group  (A/A) included 3 individuals (0 EA; 3 AA; aver-
age   % methylation =  0.0) (Fig.  4). Therefore, the DNA 
methylation difference between the two ethnicities on 
this CpG site can be completely explained by the geno-
type on rs55661361.
Patch methylation of the IL32 promoter region suppresses 
gene expression in vitro
To confirm that DNA methylation changes we report are 
transcriptionally relevant, we tested if the differentially 
methylated regions we observed in IL32 can influence 
gene expression using in vitro reporter assays. Both of the 
upstream promoter/5’-untranslated regions hypometh-
ylated in African-Americans compared to European-
Americans, in healthy individuals and in lupus patients, 
displayed decreased luminescence after being fully meth-
ylated in  vitro and inserted upstream of a Lucia lucif-
erase reporter gene compared to an identical sequence 
that remained unmethylated. The Lucia/firefly luciferase 
ratio for the unmethylated Region 1 insert (−230 to +232 
from IL32 transcription start site) was 2.43-fold greater 
than the methylated insert (P  =  0.0001). The ratio for 
unmethylated Region 2 insert (+194 to +573 from IL32 
transcription start site) was 2.74-fold greater than the 
methylated insert (P = 0.001) (Fig. 5).
Discussion
We present the first comparison of the genome-wide 
DNA methylation status of peripheral naïve CD4+ T 
cells in healthy African-American and European-Amer-
ican individuals. Site-specific methylation differences 
between ethnicities was due in part to the presence of 
genetic variants that alter the methylation status of CpG 
dinucleotides. One mechanism behind these differences 
is the disruption of the CpG dinucleotide motif recog-
nized by DNA methyltransferase 1 enzyme (DNMT1) 
[15]. DNMT1 recognizes hemi-methylated CpG dinu-
cleotides during DNA replication and methylates the 
unmethylated CpG dinucleotide on the newly synthe-
sized DNA strand. The effects of these polymorphisms in 
the genome would be a reduction in average DNA meth-
ylation of CpG sites in individuals with the disruptive 
allele. Differences in average DNA methylation would be 
greatest for CpG-SNPs that have significantly different 
allele frequencies between populations. The occurrence 
of CpG-SNPs and their effect on allele-specific meth-
ylation regions is highly population and cell-type spe-
cific. One study reported that 38–88 % of allele-specific 
methylation regions measured across 16 human adult 
and pluripotent cell lines were present solely due to CpG-
SNPs. This allele-specific methylation was also found to 
Fig. 2 Hypomethylated genes in African‑Americans that are 
connected in the literature to autoimmune diseases (a) and SLE 
(b). Thickness of the lines is proportional to how many publications 
mention each of the connections depicted, and color and size of the 
nodes are proportional to how many connections each node has in 
the network (red = most, green = fewest)
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extend beyond the individual CpG site in some instances, 
resulting in reduced methylation at nearby sites that con-
tained no overlapping SNPs [16].
The most hypomethylated CpG site in African-Amer-
icans in this study in NRGN is a prime example of the 
effect genetic variation can have on DNA methylation. 
The presence of the A allele is associated with reduced 
methylation and is the major allele in African-Ameri-
cans, but the minor allele in European-Americans. We 
demonstrated a stratification of African-American and 
European-American individuals by methylation sta-
tus and rs55661361 genotype, with African-Americans 
having significant  reduction in average DNA methyla-
tion in this locus compared to European-Americans. In 
addition to the NRGN locus, 3 others of the top 30 most 
hypomethylated CpG sites included disruptive SNPs. 
The population-specific frequency of these disruptive 
alleles varies between CEU and YRI populations. There 
are likely more CpG-SNPs across the genome that alter 
DNA methylation and account for differences between 
populations.
Neurogranin (Ng), encoded by NRGN, regulates cal-
cium-dependent apoptosis in mature T cells [17]. These 
IL-2-dependent cells express Ng and interact with the 
calcium-binding protein calmodulin. Devireddy et  al. pro-
posed an interaction model in which an IL-2 deprived 
environment increases Ng expression and Ng-calmodulin 
interaction displaces calmodulin-bound Ca2+ and thus 
raises the intercellular Ca2+ concentration, promoting apop-
tosis. It is worth noting that lupus T cells are characterized 
by defective IL-2 expression, enhanced calcium influx, and 
increased apoptosis, and that lupus is more common in 
Table 3 Differential DNA methylation between  African-American and  European-American lupus patients in  CpG sites 
identified to  be differentially hypomethylated in  healthy African-Americans and  located in  genes connected to  lupus 
using IRIDESCENT literature mining analysis




Δβ P value Location (chromosome: 
HG19 position)
cg12080831 GLI2 0.35 0.47 −0.13 7.92E−14 2:121697428
cg23112188 PCK2 0.31 0.46 −0.15 3.05E−12 14:24563095
cg22816218 RIPK1 0.71 0.85 −0.13 3.05E−12 6:3091462
cg12091331 PLAT 0.64 0.74 −0.10 3.05E−12 8:42065314
cg15844419 COL18A1 0.69 0.81 −0.12 1.35E−08 21:46850665
cg27509823 RC3H1 0.74 0.82 −0.08 1.18E−07 1:173930183
cg06193043 NPPA 0.64 0.74 −0.10 5.32E−06 1:11908199
cg00471190 IL32 0.23 0.36 −0.13 6.86E−06 16:3115809
cg00239353 IL32 0.53 0.72 −0.19 7.62E−06 16:3115133
cg20135711 ITGB7 0.70 0.80 −0.10 2.13E−05 12:53592259
cg17330251 PON1 0.49 0.62 −0.13 9.24E−05 7:94953956
cg23813257 IL32 0.24 0.32 −0.08 1.06E−04 16:3115286
cg01874867 PON1 0.45 0.57 −0.12 1.35E−04 7:94954059
cg19678392 PON1 0.55 0.66 −0.11 1.70E−04 7:94953810
cg20768743 CD226 0.17 0.24 −0.07 2.24E−04 18:67624846
cg04871131 PON1 0.62 0.72 −0.10 3.28E−04 7:94954202
cg08978665 IL32 0.31 0.40 −0.10 4.00E−04 16:3115707
cg09035930 SLC15A4 0.67 0.77 −0.11 7.40E−04 12:129282057
cg20119798 PON1 0.50 0.61 −0.10 7.68E−04 7:94954144
cg22216157 PTPRN2 0.68 0.79 −0.10 7.68E−04 7:157643037
cg24425727 CDKN1A 0.28 0.35 −0.06 2.81E−02 6:36645648
cg04548204 KLRG1 0.37 0.45 −0.08 5.99E−02 12:9162872
cg27473997 USP17 0.73 0.78 −0.05 9.89E−02 4:9355351
cg22798247 TAP2 0.84 0.86 −0.02 9.89E−02 6:32807372
cg18938907 GSTM1 0.28 0.22 0.05 3.83E−01 1:110230456
cg11680055 GSTM1 0.23 0.25 −0.02 5.38E−01 1:110230252
cg24506221 GSTM1 0.19 0.21 −0.02 7.71E−01 1:110230401
cg10950028 GSTM1 0.39 0.40 0.00 9.09E−01 1:110230633
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Fig. 3 Analysis of the transcriptional correlation of 144 genes hypomethylated in African‑American naïve CD4+ T cells was conducted by calculat‑
ing Pearson’s correlation coefficients of the reported transcriptional fold changes across 3900 human 2‑color microarray data sets. Correlation values 
range from 1.0 (perfect positive correlation represented in red) to −1.0 (perfect negative correlation represented in green). Three blocks of transcrip‑
tionally co‑regulated genes can be seen in the colored squares. Using literature mining, the highest scoring themes among the genes in the yellow, 
blue and purple blocks are the cytokine IL‑2, cell migration, and the glutathione S‑transferase gene GSTO1, respectively
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African-Americans compared to European-derived popu-
lations [18]. Further, recent reports suggest increased Ng 
expression in PBMCs of lupus patients [19, 20].
Apoptosis was found to be a recurring theme among 
genes associated with hypomethylated CpG sites in naïve 
CD4+ T cells from African-American individuals.
Gene ontology terms for the hypomethylated genes 
show an enrichment of cellular apoptosis driven by the 
hypomethylation of genes such as TNFRSF10A, COL18A1, 
CDKN1A, AHRR, UNC13D, RIPK1, GRIN1, AKAP13, 
VAV2, and PRODH. Tumor necrosis factor receptor super-
family, member 10a (or TRAILR1) is a cell surface protein 
encoded by TNFRSF10A. It recognizes extracellular Apo-
2L (or TRAIL) and acts as a signal for the downstream 
recruitment of pro-apoptotic caspases in the cell [21].
Four CpG sites upstream of the cytokine gene IL32 
were hypomethylated in African-American individu-
als independently of any known SNP. An 803-bp region 
(chr16:3115083–3115886; HG19) immediately upstream 
of and including the IL32 gene transcription start site 
and its 5’-untranslated region contained these four 
CpG sites. These sites were cloned with their surround-
ing sequence and inserted into a CpG-free luciferase 
reporter vector. The unmethylated and in  vitro methyl-
ated regions were compared and showed a significant 
reduction in the expression of luciferase in transfected 
HEK 293 cells when all CpG sites were methylated. These 
regions contain regulatory elements that are influenced 
by DNA methylation and could regulate the expres-
sion of IL32 in peripheral T cells. IL-32 is a cytokine 
that induces the production of MIP-2, IL-8 and TNF 
in monocytic cell lines [22]. IL-32 (primarily IL-32β) 
expression in activated CD4 + T cells was also associated 
with increased apoptosis and was presumed to play a role 
in activation-induced cell death [23]. The hypomethyla-
tion of apoptosis-related genes could indicate an epige-
netic susceptibility to apoptosis and might contribute 
to the pathogenesis of diseases in which T cell apopto-
sis is an associated factor. A significant increase in T cell 
apoptosis has been reported in SLE patients compared 
to controls [24]. Apoptosis was also increased in active 
(SLE Disease Activity Index >4) SLE patients compared 
to inactive patients. Taken together, hypomethylation of 
pro-apoptotic genes in naïve CD4+ T cells from healthy 
African-Americans may contribute to the increased fre-
quency and severity of lupus in African-Americans.
Fig. 4 The CpG‑SNP rs55661361 (A > G) in NRGN has an allele 
frequency that differs between CEU and YRI populations (a). Bisulfite 
sequencing of the CpG‑SNP region in healthy individuals (b) revealed 
three distinct methylation categories based on being heterozygous 
or homozygous for the disruptive A allele [high methylation (G/G); 
intermediate methylation (G/A); low methylation (A/A)]. A cartoon 
(c) demonstrating the effect of the A allele on cytosine methylation 
by DNMT1. Average DNA methylation levels in NRGN stratified by 
genotype in 31 healthy individuals included in the study (d). Geno‑
type, average methylation ± SD, N: G/G, 0.82 ± 0.07, N = 15; G/A, 
0.56 ± 0.07, N = 13; A/A, 0 ± 0, N = 3
Fig. 5 Using a luciferase reporter vector with an inserted 
promoter/5’‑untranslated regions from IL32 shows a significant 
difference in luciferase expression between fully methylated and 
unmethylated regions as measured by a ratio of Lucia luciferase over 
firefly luciferase luminescence. A cartoon (a) of the linearized plasmid 
showing the location of the IL32 promoter/5’‑untranslated region 
inserts in the Lucia Luciferase reporter vector and the number of CpG 
sites present in each insert. The expression of the Lucia luciferase 
reported as a ratio of Lucia/firefly luciferase (b)
Page 9 of 13Coit et al. Epigenetics & Chromatin  (2015) 8:49 
The glutathione S-transferase mu 1 protein (GSTM1) 
encoded by GSTM1 is involved in the metabolism of 
xenobiotic compounds including carcinogens and prod-
ucts of oxidative stress. It plays a role in processing car-
cinogens and has been previously associated with cancer 
risk [25]. There were 4 CpG sites in GSTM1, two within 
200 bp upstream of the transcription start site, one in the 
1st exon, and one in the gene body, with significant hypo-
methylation in African-American naïve CD4+ T cells.
We also found significant hypomethylation in CD226 
in African-American naïve CD4+ T cells. CD226 is 
expressed on the surface of T cells and natural killer T 
cells. It is involved in the activation, adhesion, cytotox-
icity, and differentiation of T cells, and has previously 
been identified as a genetic risk locus for SLE [26]. The 
risk locus is located downstream of the CD226 gene body 
while the demethylated CpG site is within 1500 bp of the 
transcription start site.
In summary, we identified significant epigenetic dif-
ference in naïve CD4+ T cells between African-Ameri-
can and European-American healthy individuals. These 
ethnicity-specific epigenetic differences are at least in 
part derived from cis-acting genetic polymorphisms. 
We found significant hypomethylation in pro-apoptotic 
genes in African-Americans, and hypomethylation of 
pro-inflammatory genes such as IL32. This epigenetic 
variability might play a role in increased frequency and 
severity of some autoimmune diseases such as lupus, 
which is characterized by increased T cell apoptosis. 
Indeed, of the 144 hypomethylated genes in African-
American naïve CD4+ T cells, 18 and 27 have been 
previously related to lupus and autoimmune diseases, 
respectively. We demonstrated that the majority of these 
18 lupus-related genes were also hypomethylated in Afri-
can-American compared to European-American lupus 
patients, providing further validation and disease-rele-
vance of the ethnicity-specific DNA methylation changes 
reported in this study. Further work is required to deter-
mine if these hypomethylated sites exist in a transient 
state or are maintained as the cell develops, and whether 
or not they are relevant to other cell types. Exploration 
of the DNA methylome could help further resolve what 
inherent epigenetic differences in immune activity exist 
among populations that might influence the pathogenesis 
of complex heterogeneous diseases.
Conclusion
We provide evidence for wide-spread ethnicity-spe-
cific differences in DNA methylation patterns in naïve 
CD4+ T cells. These differences promote an over-
all T cell chromatin architecture that is more permis-
sive to autoimmunity in African-Americans compared 
to European-Americans. Indeed, hypomethylated loci 
in African-Americans are enriched in pro-apoptotic 
genes involved in autoimmunity. These same genes are 
also hypomethylated in African-American compared to 
European-American lupus patients. Our data also pro-
vide strong evidence that these methylation differences 
between ethnicities are at least in part a result of genetic 
variants that directly disrupt CpG dinucleotides. There-
fore, inherited epigenetic susceptibility loci contribute 
to explaining differences in susceptibility to autoimmune 
diseases, including lupus, between populations.
Methods
Study participants
A total of 66 healthy female individuals (21 African-
Americans and 45 European-Americans) were recruited 
for our studies. There was no significant difference in age 
between the African-American (mean age = 39.3 years) 
and European-American (mean age  =  42.5  years) 
groups (P value = 0.34). All study participants signed an 
informed consent prior to enrollment into the study. The 
institutional review boards at the University of Michigan 
and the Henry Ford Health System approved this study. 
To validate the relevance of detected ethnicity-specific 
DNA methylation differences in an autoimmune disease, 
a group of age-matched 21 African-American and 42 
European-American female lupus patients were studied. 
All patients met the American College of Rheumatology 
classification criteria for SLE [27].
Isolation of naïve CD4+ T cells
Whole blood was collected at the time of enrollment and 
processed within 6 h of collection. Peripheral blood mon-
onuclear cells were isolated using Ficoll density gradient 
centrifugation media (GE Healthcare Biosciences, USA) 
followed by indirect isolation of untouched naïve CD4+ 
T cells using the Naïve CD4+ T cell Isolation Kit II 
(Miltenyi Biotec Inc., USA). DNA was isolated using the 
DNeasy Blood and Tissue Kit (Qiagen, USA) and DNA 
concentration was determined by spectrophotometry 
on the NanoDrop 2000 (Thermo Scientific, USA). Flow 
cytometry was used to confirm purity of isolated naïve 
CD4+ T cells using CD4 and CD45RA fluorochrome-
conjugated antibodies (BioLegend, USA).
DNA methylation analysis
500 ng of DNA from each sample was bisulfite converted 
using the EZ DNA Methylation™ Kit (Zymo  Research, 
USA) as previously described [6]. DNA methylation was 
evaluated by hybridizing bisulfite-converted DNA to the 
Infinium HumanMethylation450 BeadChips (Illumina, 
USA) according to manufacturer’s directions. The Infin-
ium array interrogates over 485,000 methylation sites 
across the human genome, covering 96 % of CpG islands, 
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shores and flanking regions as well as 99  % of RefSeq 
genes with an average of 17 CpG sites per gene region. 
The array covers the promoter, 5′-untranslated region, 
first exon, gene body, and 3′-untranslated region of each 
gene. Array hybridization of the bisulfite-converted 
DNA was performed at the University of Michigan DNA 
Sequencing Core.
Methylation data processing and analysis
DNA methylation data analysis was performed using the 
minfi (1.12.0) statistical analysis package in the R environ-
ment (3.1.2) [28, 29] (Additional file 1: Figure S1). Minfi 
is an analysis suite for Infinium HumanMethylation450 
data that allows user flexibility in preprocessing, quality 
control, and identification of differentially methylated 
regions. Raw data were imported into minfi as a single 
object of red and green channel intensity values and sam-
ple phenotype information. Preprocessing of these chan-
nel values was accomplished using a method included in 
minfi that is equivalent to the data preprocessing method 
in the Illumina GenomeStudio Methylation Module that 
converts the red and green channel intensities into meth-
ylated and unmethylated values. This included correction 
for background signal and normalization of each channel 
to control probes included on each array. An array was 
chosen at random for normalization. After preprocess-
ing, 306 probes with a detection P value >0.05 in >20 % 
of the probes were removed from analysis. 60,045 probes 
were identified as having a SNP within 10 base pairs of 
the interrogated nucleotide and were removed from anal-
ysis as well. Using minfi’s “fixMethOutliers” command, 
extreme values in the methylated and unmethylated 
channels were identified separately. An intensity cutoff 
value was calculated by first log2(x + 0.5) transforming all 
intensity values and then calculating the median inten-
sity and median intensity absolute deviation. An intensity 
cutoff was defined as the median +  (−3 * median abso-
lute deviation). Any intensity less than the cutoff value 
was considered an outlier, and adjusted to be equal to 
the intensity cutoff. The methylated and unmethylated 
probe values were used to calculate both a Beta (β) and 
M value ratio. β values are calculated using the formula: 
β =
Methylated
Methylated + Unmethylated + 100
 and M values are calcu-
lated as the logit(β).
Batch effect correction was performed using the 
ComBat script available as part of the sva (3.12.0) pack-
age [30]. ComBat utilizes a parametric empirical Bayes 
method to first standardize means and variances across 
batches for normalized data. Next it  uses the distribu-
tion of the standardized data to determine batch effect 
parameters, and finally, uses the empirically determined 
batch effect estimators to adjust the data. Individual 
Infinium microarray chips used were input into ComBat 
as batches. M values were calculated from normalized β 
values and used as input for ComBat, as it assumes a nor-
mal distribution of the data, and the batch effect-adjusted 
matrix of data was converted back into β values for fur-
ther analysis.
After adjusting for batch effect, the delta β (Δβ) of 
each probe between the African-American and Euro-
pean-American groups was calculated as ∆β =Mean 
β(African− American)−Meanβ(European− American)  . 
A two-sided Student’s t test was performed assuming 
equal variances of the mean β in each group to calculate 
a P value adjusted for false discovery rate (FDR). Further 
analysis was limited to probes with an FDR-adjusted P 
value of less than or equal to 0.05 and a |Δβ| greater than 
0.1.
Gene ontology and bioinformatics analysis
Gene ontologies (GO) identification of hypo- and hyper-
methylated probes was performed using the Database 
for Annotation, Visualization and Integrated Discovery 
(DAVID v6.7) [31, 32]. Search parameters used in DAVID 
were a minimum gene group membership of 2, a Modi-
fied Fisher Exact P value (EASE Score) maximum of 0.1, 
and the human genome as background. Further bioinfor-
matics analysis was conducted using IRIDESCENT [12].
Bisulfite DNA sequencing
Confirmation of the methylation status reported by the 
BeadChip array for each donor was conducted by first 
bisulfite converting 100  ng of genomic DNA from 31 
samples (21 EA; 10 AA) as described earlier in this paper. 
Polymerase chain reaction (PCR) was used to amplify a 
581-bp region of NRGN (chr11:124613509–124614089; 
HG19) using forward (5′-GAATGTGAAGTTTAGGA 
AATGAGGT-3′) and reverse (5′-TTCAACCTAAT 
AATAATCAAACCCACCTCT-3′) primers added to 
ZymoTaq™ PreMix (Zymo  Research, USA). PCR ther-
mocycler settings were as follows: DNA denatura-
tion at 95  °C for 10  min followed by 40 cycles at 95  °C 
for 30 s, then 56 °C for 40 s, and finally 72 °C for 1 min. 
PCR amplification of the desired region was confirmed 
by electrophoresis of an aliquot from each product on 
a 2.0 % agarose gel at 93 V for 1 h. The remaining PCR 
product was prepared for sequencing using the DNA 
Clean and Concentrator-5 Kit (Zymo Research, USA) fol-
lowing manufacturer’s directions and DNA concentra-
tion was determined using the NanoDrop 2000 (Thermo 
Scientific, USA). Sequencing was performed on an ABI 
Model 3730XL sequencing platform. Average DNA 
methylation and genotypes were determined using Epige-
netic Sequencing MEthylation (ESME) analysis software 
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[33]. β values determined by ESME and the Human-
Methylation450 array showed a high, positive correlation 
(R2 = 0.8217).
Co‑regulation analysis of hypomethylated genes
The co-expression of 144 hypomethylated genes was 
determined using 3900 processed, 2-color human gene 
expression microarrays retrieved from the Gene Expres-
sion Omnibus as previously described [14]. Global gene–
gene pair co-expression was quantified using Pearson’s 
correlation coefficients.
Ligation of IL32 promoter regions into luciferase reporter 
vector
Two regions containing CpG sites of interest within the 
IL32 promoter/5’-untranslated regions were amplified 
from human genomic DNA. Region 1 (chr16:3115083–
3115545; HG19) (forward primer: 5′-TTTGAGCTCC-
CTATCTTGTCCCACAGGTAGA-3′, reverse primer: 
5 ′-AGGTACTCGAGACAGACAGAGACAGAGA-
CAGAG-3′) contains cg00239353, cg26724967, and 
cg23813257 and region 2 (chr16:3115507–3115886; 
HG19) (forward primer: 5′-CCCGAGCTCTCTCTGTC 
TGTCTCTGTCTCTG-3′, reverse primer: 5′-ATGTAC 
TCGAGGCACCCTTACGGTCTGTTT-3′) contains 
cg18350391, cg08978665, and cg00471190. These regions 
also contained other CpG sites not included on the 
Infinium array. The PCR thermocycler conditions used 
were as follows: 30 s at 98 °C, and 3 cycles of 98 °C for 
10  s followed by 67  °C for 30  s followed by 72  °C for 
20 s, and 27 cycles of 98  °C for 10 s followed by 58  °C 
for 30 s followed by 72 °C for 20 s, and 2 min at 72 °C. 
Each amplified region was Sanger sequenced to ver-
ify the correct sequence was amplified. The correctly 
amplified regions were ligated using T4 DNA ligase 
(New England BioLabs, USA) into a CpG-free Lucia 
luciferase reporter vector (pCpGfree-Lucia; Invivo-
Gen, USA) (Fig.  5a) digested with ScaI. Both regions 
were inserted immediately upstream of a human EF1 
promoter. Each ligation reaction contained a 5:1 insert: 
vector molar ratio, and was incubated overnight at 
16 °C, then incubated 30 min at room temperature and 
heat inactivated at 65 °C.
The plasmids were transformed into E. coli GT115 
(InvivoGen, USA) using the Mix and Go E. coli trans-
formation kit (Zymo  Research, USA) with 1  h of out-
growth, and grown on Zeocin selective plates and media 
(InvivoGen, USA). Plasmid DNA from transformed 
liquid cultures was extracted using the QIAprep Spin 
Miniprep Kit (Qiagen, USA), and the direction of each 
insert within the plasmid was determined by Sanger 
sequencing using the forward primer previously listed 
for each region.
Patch methylation of IL32‑promoter region
0.5  µg of each complete plasmid were methylated via 
M.SssI methyltransferase (New England BioLabs, USA) 
or mock methylated (methyltransferase omitted). Each 
methylation reaction contained 640 mM S-adenosylme-
thionine and 16U M.SssI, and was incubated overnight at 
37 °C and heat inactivated at 65 °C for 20 min. The CpG-
free promoter vector is modified to contain no CpG sites, 
so the inserted promoter regions are exclusively meth-
ylated. Complete methylation was verified by digesting 
100  ng of plasmid with SacI and methylation-sensitive 
restriction enzymes (HpyCH4IV for region 1, and AciI for 
region 2) at 37 °C for 1 h (New England BioLabs, USA). 
For region 1, the expected digestion product size was 
either 3.7 kb if methylated or 1.8 kb if unmethylated. For 
region 2, the expected product size was 3.7 kb if methyl-
ated or 1.6 and 1.9 kb if unmethylated. Only methylation 
reactions that were verified as completely methylated by 
gel electrophoresis were used in transfection.
Luciferase reporter assay of methylated and unmethylated 
IL32 promoter regions
HEK 293 cells in an opaque white 96 well plate were 
transfected in triplicate with 50  ng control firefly lucif-
erase plasmid (Promega, USA) and 50  ng of pCpG-
free-Lucia constructs, using Lipofectamine 3000 
(Invitrogen, USA) according to manufacturer’s instruc-
tion. The pCpGfree-Lucia constructs used  were either 
the methylated or mock methylated plasmids containing 
either region 1 or region 2, as well as a vector containing 
no insert, and a DNA-free control. After 48 h, the lucif-
erase activity was measured after simultaneously treating 
an aliquot of the supernatant media with QUANTI-Luc 
reagent (InvivoGen, USA)  to measure Lucia luciferase 
activity, and treating the adherent cells with Dual-Glo 
Luciferase reagent (Promega, USA)  to measure firefly 
luciferase activity, and immediately reading the result-
ing luminescence with a Synergy H1 microplate reader 
(BioTek, USA) with a gain of 100 units. The reads were 
background corrected to the DNA-free control, then 
controlled for transfection efficiency by reporting the 
ratio of Lucia/firefly luciferase luminescence. These ratios 
were compared to determine the effect of methylation on 
luciferase activity using a Student’s t test with a statistical 
significance threshold of α ≤ 0.05 (Fig. 5b).
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